The Clinical Significance of Peripherally Inserted Central Venous Catheter-Related Deep Vein Thrombosis

被引:46
作者
Fletcher, Jeffrey J. [1 ,2 ]
Stetler, William [2 ]
Wilson, Thomas J. [2 ]
机构
[1] Univ Michigan Hosp & Hlth Ctr, Dept Neurosurg, Taubman Hlth Care Ctr 3552, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Neurosurg, Taubman Hlth Care Ctr 3552, Ann Arbor, MI 48109 USA
关键词
Central venous catheterization; Upper extremity deep venous thrombosis; Secondary upper extremity deep vein thrombosis; Venous thrombosis; Central venous catheter thrombosis; RETROSPECTIVE ANALYSIS; PULMONARY-EMBOLISM; RISK-FACTORS; THROMBOEMBOLISM; COMPLICATIONS;
D O I
10.1007/s12028-011-9554-3
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Peripherally inserted central venous catheters (PICCs) are being increasingly utilized in hospitalized patients as alternatives to centrally inserted central venous catheters (CICVCs). However, concern exists over the risk of PICC-related large vein thrombosis (PRLVT). The incidence rate and significance of symptomatic PRLVT in critically ill patients admitted to the neurological intensive care unit (ICU) is not known. Retrospective descriptive study of consecutive PICCs placed in critically ill patients admitted to a tertiary care neurological ICU between March 2008 and February 2010. Symptomatic PRVLT was defined as an event that prompted Duplex ultrasound of the ipsilateral extremity in which an acute, proximal large vein thrombosis was confirmed in association with the PICC or confirmed within 5 days of PICC removal. Incidence rate of PRLVT and catheter-related complications were calculated per "line" (catheter). Descriptive statistics were performed with two-sample, and t-tests for age and categorical variables were assessed by Chi-square test or Fishers exact test as appropriate Four hundred and seventy-nine lines were placed during the study period with 39 developing a symptomatic PRLVT (incidence rate = 8.1%). Male gender was associated with development of a thrombosis (P = 0.02), but size (P = 0.21) and location of catheter were not (P = 0.30). Median line dwell time was 12 days (IQR 16) with a dwell time of 8 days (IQR 9) until thrombosis diagnosis. Pulmonary embolus attributed to PRLVT occurred in 1.3% of line placements and 15% of symptomatic PRLVT. The majority of patients had their line removed. In addition, some patients also had anticoagulation initiated or a superior vena cava filter placed. Symptomatic PRLVT is not uncommon in critically ill patients admitted to the neurological ICU. Future research should focus on indentifying modifiable risk factors for PRLVT and on comparing major cumulative complication rates between PICCs and CICVCs.
引用
收藏
页码:454 / 460
页数:7
相关论文
共 22 条
[1]   Incidence of upper limb venous thrombosis associated with peripherally inserted central catheters (PICC) [J].
Abdullah, JJ ;
Mohammad, N ;
Sangkar, JV ;
Aziz, YFA ;
Gan, GG ;
Goh, KY ;
Benedict, I .
BRITISH JOURNAL OF RADIOLOGY, 2005, 78 (931) :596-600
[2]   Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients [J].
Bonizzoli, Manuela ;
Batacchi, Stefano ;
Cianchi, Giovanni ;
Zagli, Giovanni ;
Lapi, Francesco ;
Tucci, Valentina ;
Martini, Giacomo ;
Di Valvasone, Simona ;
Peris, Adriano .
INTENSIVE CARE MEDICINE, 2011, 37 (02) :284-289
[3]   Venous thrombosis associated with peripherally inserted central catheters: A retrospective analysis of the Cleveland Clinic experience [J].
Chemaly, RF ;
de Parres, JB ;
Rehm, SJ ;
Adal, KA ;
Lisgaris, MV ;
Katz-Scott, DS ;
Curtas, S ;
Gordon, SM ;
Steiger, E ;
Olin, J ;
Longworth, DL .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) :1179-1183
[4]   Risk of Symptomatic DVT Associated With Peripherally Inserted Central Catheters [J].
Evans, R. Scott ;
Sharp, Jamie H. ;
Linford, Lorraine H. ;
Lloyd, James F. ;
Tripp, Jacob S. ;
Jones, Jason P. ;
Woller, Scott C. ;
Stevens, Scott M. ;
Elliott, C. Gregory ;
Weaver, Lindell K. .
CHEST, 2010, 138 (04) :803-810
[5]   Changing concepts in long-term central venous access: Catheter selection and cost savings [J].
Horattas, MC ;
Trupiano, J ;
Hopkins, S ;
Pasini, D ;
Martino, C ;
Murty, A .
AMERICAN JOURNAL OF INFECTION CONTROL, 2001, 29 (01) :32-40
[6]   Antithrombotic therapy for venous thromboembolic disease [J].
Kearon, Clive ;
Kahn, Susan R. ;
Agnelli, Giancarlo ;
Goldhaber, Samuel ;
Raskob, Gary E. ;
Comerota, Anthony J. .
CHEST, 2008, 133 (06) :454S-545S
[7]   Peripherally inserted central venous catheter-associated thrombosis: Retrospective analysis of clinical risk factors in adult patients [J].
King, Melissa M. ;
Rasnake, Mark S. ;
Rodriguez, Rechell G. ;
Riley, Nancy J. ;
Stamm, Jason A. .
SOUTHERN MEDICAL JOURNAL, 2006, 99 (10) :1073-1077
[8]   Prevention of central venous catheter-associated thrombosis: A meta-analysis [J].
Kirkpatrick, Angelia ;
Rathbun, Suman ;
Whitsett, Thomas ;
Raskob, Gary .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (10) :901-U19
[9]   Complications of central venous catheterization [J].
Kusminsky, Roberto E. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2007, 204 (04) :681-696
[10]   Risk of Venous Thromboembolism in Hospitalized Patients with Peripherally Inserted Central Catheters [J].
Lobo, Bob L. ;
Vaidean, Georgeta ;
Broyles, Joyce ;
Reaves, Anne B. ;
Shorr, Ronald I. .
JOURNAL OF HOSPITAL MEDICINE, 2009, 4 (07) :417-422